CACC
Credit Acceptance Corporation
CACC offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
MS
Morgan Stanley
MS has the edge over CACC overall, supported by stronger fundamentals and stronger modeled upside.
CACC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
CACC's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like CACC.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
CACC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 9.3x | $504 | — |
| Cheap | 10x | $318 | -37% |
| Fair | 14x | $417 | -17% |
| Current | 17x | $504 | — |
| Expensive | 25x | $752 | +49% |
Historical ranges are pointers, not guarantees.
CACC's PE is 17x, but its earnings don't support one, so it isn't a reliable read right now.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS has the edge over CACC in the historical PE scenario, which offers more potential upside but is not a forecast.
CACC Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for CACC, with profitability improving.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
CACC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $53.86 | +77% |
| Q3 2026 | $30.50 | -19% |
| Q2 2026 | $45.36 | +31% |
| Q1 2026 | $40.12 | +71% |
| Q4 2025 | $36.38 | +83% |
| Q3 2025 | $37.79 | +154% |
| Q2 2025 | $34.71 | +149% |
| Q1 2025 | $23.46 | +21% |
| Q4 2024 | $19.88 | -9.6% |
CACC's earnings per share have fallen from their peak: $30.50 over the past year, against $62.64 in early 2022. Its recent earnings include one-off gains.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS's earnings per share have climbed steadily: $12.60 over the past year, up 29% from the year before, and higher year over year for 10 quarters in a row.
CACC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $594.6M | +2.1% |
| Q2 2026 | $587.4M | +0.6% |
| Q1 2026 | $580M | +1.6% |
| Q4 2025 | $579.9M | +2.5% |
| Q3 2025 | $582.4M | +5.8% |
| Q2 2025 | $583.8M | +8.5% |
| Q1 2025 | $571.1M | +12% |
| Q4 2024 | $565.9M | +15% |
CACC's revenue has grown year over year for 14 quarters in a row: $595M last quarter, up 2.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -12% | -38 points |
| Q2 2026 | 29% | +8.5 points |
| Q1 2026 | 30% | +5.4 points |
| Q4 2025 | 27% | -6.8 points |
| Q3 2025 | 26% | +6.2 points |
| Q2 2025 | 20% | +30 points |
| Q1 2025 | 25% | +7.8 points |
| Q4 2024 | 34% | +10 points |
CACC's operating margin was −12% last quarter, down 38 points from the same quarter a year ago, near the bottom of its range since 2019.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over CACC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS has the edge over CACC on profitability, with a higher operating margin.
CACC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $334.1M | +12% |
| Q2 2026 | $307.9M | +121% |
| Q1 2026 | $345.5M | -0.1% |
| Q4 2025 | $268.9M | -12% |
| Q3 2025 | $298.8M | -5.8% |
| Q2 2025 | $139.4M | -32% |
| Q1 2025 | $345.9M | +12% |
| Q4 2024 | $305.5M | -1.3% |
CACC has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
CACC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3% | -318K shares |
| 1 year | -9.2% | -1.1M shares |
| 3 years | -20% | -2.6M shares |
| 5 years | -34% | -5.4M shares |
| Available history | -45% | -8.6M shares |
CACC has the edge over MS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $161.6M |
| Q2 2026 | $141.4M |
| Q1 2026 | $178.9M |
| Q4 2025 | $191.4M |
| Q3 2025 | $107.4M |
| Q2 2025 | $262.2M |
| Q1 2025 | $164.4M |
| Q4 2024 | $61.4M |
CACC spent $673M buying back its own shares over the past year, up 13% from the year before.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has 1.6B diluted shares, down 1.5% from a year ago.
CACC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 13.1x | High |
| Q2 2026 | 8.0x | High |
| Q1 2026 | 8.8x | High |
| Q4 2025 | 9.2x | High |
| Q3 2025 | 8.7x | High |
| Q2 2025 | 9.5x | High |
| Q1 2025 | 13.0x | High |
| Q4 2024 | 14.9x | High |
CACC's net debt is about 13 years of its operating earnings (EBITDA), up from 8.7 years a year ago. Net leverage isn't a meaningful measure for financial services companies like CACC.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS has the edge over CACC on leverage, with a lower net debt burden relative to earnings.
CACC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.5 | Neutral |
| Stochastic | 26.5 | Neutral |
CACC's weekly RSI is 44 (neutral) and its Stochastic is 26 (neutral).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
CACC PE vs Financial Services Sector
| Metric | CACC | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 13x | 27% above |
| PE % | 65 | 63 | 2 pts above |
CACC is trading at 17x earnings, a 27% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS has the edge over CACC on valuation relative to its sector.
CACC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $526.9 | 4.4% below |
| 20 week MA | $571.9 | 12% below |
| 50 week MA | $526.5 | 4.4% below |
| 100 week MA | $506.2 | 0.5% below |
| 200 week MA | $496.6 | 1.4% above |
CACC has fallen below most of its moving averages, though it's still 1.4% above its 200-week average.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS has the edge over CACC on trend strength, trading above more of its moving averages.
CACC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $437.2 | $329.0 | -25% |
| 2021 | $329.0 | $680.0 | +107% |
| 2022 | $680.0 | $465.2 | -32% |
| 2023 | $465.2 | $532.7 | +15% |
| 2024 | $532.7 | $469.2 | -12% |
| 2025 | $469.2 | $457.2 | -2.6% |
| 2026 YTD | $457.2 | $503.5 | +10% |
CACC has the edge over MS on returns for 2026, with the stronger performance.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.